Redox and Curative Partner to Connect COVID-19 Test Results to Public Health Departments

Patient Data Integration Helps Inform Policies for Contact Tracing and Phased Openings

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Redox, Inc., the leading interoperability platform for healthcare data exchange, is working with FDA-authorized COVID-19 testing company Curative to safely connect patient data to state public health departments for notification of results.

Redox notes since formalizing the partnership in May, the duo has kicked off projects with 24 states, with two, Illinois and Delaware, now fully live.

Other COVID-19 tests, such as the nasal swab and oral-based approach, are difficult for consumers to handle, are hard to administer en masse, or may pose a risk of exposure for healthcare workers. Curative offers an easy to use, accurate, and rapidly scalable oral fluid-based testing method that is less invasive, and which distributes results within just 48 hours. Using its connection with Redox, Curative immediately sends test results to state officials for reporting, contact tracing programs, and to inform policies as regions move through phases for opening the economy.

“Every state has its own unique, mandatory reporting requirements for COVID-19 testing. This can be challenging for an organization like ours, which is so focused on working as quickly as possible to scale up testing services nationwide,” said Isaac Turner, CIO and co-founder, Curative. “Redox has given us a secure and scalable integration strategy to quickly automate this reporting requirement across all the different systems we need to work with. Redox allows us to be confident that this critical data will get to the right destination, in the proper format, and in a timely manner, so we can continue to focus on scaling out COVID-19 testing across the nation.”

Redox standardizes healthcare data with a vendor-agnostic application programming interface (API) and a cloud network where organizations can exchange information. This networked approach to interoperability simplifies the way organizations exchange healthcare data by normalizing data formats and eliminating redundant connections. In this novel use case, Curative utilizes the Redox API to allow for a secure, efficient flow of data between it and public health authorities, further extending Redox’s network of more than 700 healthcare delivery organizations to include state public health agencies and regional HIEs.

“As we start to safely reopen the economy, state officials must have an accurate and efficient testing and contact tracing system,” said Niko Skievaski, co-founder and president of Redox. “Curative’s simpler, safer process has taken testing to a new level, and together with Redox, we’ll help to not only control the spread of the disease but also be better able to allocate healthcare resources appropriately. We hope this will become a core piece of public health infrastructure.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

ArisGlobal Reports | Newest Version of LifeSphere® Regulatory Platform Launches

Ann-Marie Orange, CIO & Global Head of R&D shares, “With more than 35 years of experience in life sciences technology, ArisGlobal is the only technology company offering strong Safety, Regulatory, and Quality Management solutions powered with next-generation cognitive computing, delivering unmatched interoperability across the R&D IT ecosystem. Over the last 18 months ArisGlobal has made significant investment in the strategic acquisitions of Amplexor Life Sciences and SPORIFY, along with technology R&D – and we’re not stopping.”
Exit mobile version